Investigation of Isoindolo[2,1-a]quinoxaline-6-imines as Topoisomerase I Inhibitors with Molecular Modeling Methods

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|13|3|208-221

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.13, Iss.3, 2017-07, pp. : 208-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Designing Type II Topoisomerase Inhibitors: A Molecular Modeling Approach

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 40-50

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of the topoisomerase I inhibitors

By Seiter Karen  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 45-53

Informa Healthcare

Access to resources Recommend Favorite

Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors

By Beretta Giovanni Luca   Perego Paola   Zunino Franco  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1243-1256

Informa Healthcare

Access to resources Recommend Favorite

Discovery of 5,6-Dihydro-indolo[1,2-a]quinoxaline Derivatives as New HIV-1 Inhibitors In Vitro

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 44-47

Bentham Science Publishers

Access to resources Recommend Favorite

In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-10 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite